Crispr Therapeutics shares owned by SFE Investment Counsel
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by SFE Investment Counsel
from 13F filings
Historical chart of SFE Investment Counsel investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by SFE Investment Counsel consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by SFE Investment Counsel
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $242k | 6.2k | 39.36 |
| 2024-09-30 | $297k | 6.3k | 46.98 |
| 2024-06-30 | $316k | 5.8k | 54.01 |
| 2024-03-31 | $385k | 5.6k | 68.16 |
| 2023-12-31 | $307k | 4.9k | 62.60 |